大博医疗
(002901)
| 流通市值：96.22亿 | | | 总市值：138.08亿 |
| 流通股本：2.89亿 | | | 总股本：4.14亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,011,928,158.97 | 993,830,861.47 | 975,716,855.44 | 1,227,869,040.94 |
| 应收票据及应收账款 | 265,370,017.42 | 267,839,605.62 | 242,674,847.34 | 242,409,985.86 |
| 其中：应收票据 | 200,000 | 400,000 | 200,000 | - |
| 应收账款 | 265,170,017.42 | 267,439,605.62 | 242,474,847.34 | 242,409,985.86 |
| 预付款项 | 55,244,229.6 | 41,613,776.77 | 37,357,436.13 | 22,007,272.04 |
| 其他应收款合计 | 12,011,460.75 | 11,757,325.61 | 12,770,399.13 | 10,456,534.99 |
| 存货 | 1,269,930,625.27 | 1,203,417,193.34 | 1,198,071,796.2 | 1,193,260,039.88 |
| 合同资产 | 108,300 | 108,300 | 108,300 | 108,300 |
| 其他流动资产 | 16,072,997.85 | 20,370,231.14 | 16,573,647.67 | 26,053,168.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,881,863,831.91 | 2,933,299,976.26 | 3,091,003,678.66 | 3,155,364,707.34 |
| 非流动资产: | | | | |
| 固定资产 | 1,056,687,512.11 | 1,067,447,996.68 | 801,653,024.04 | 814,002,969.87 |
| 在建工程 | 96,074,757.55 | 52,140,227.39 | 298,336,303.03 | 238,247,860.95 |
| 使用权资产 | 14,610,564.45 | 15,829,533.81 | 17,167,812.99 | 18,610,098.3 |
| 无形资产 | 127,626,089.63 | 130,692,111.53 | 133,878,509.31 | 136,923,395.85 |
| 商誉 | 67,914,231.34 | 67,618,296.31 | 67,912,535.9 | 68,274,928.12 |
| 长期待摊费用 | 202,542,676.25 | 203,316,347.65 | 198,265,430.62 | 197,486,258.46 |
| 递延所得税资产 | 11,368,424.01 | 10,761,965.84 | 8,785,799.92 | 8,930,876.58 |
| 其他非流动资产 | 2,144,029.94 | 1,930,020.93 | 1,930,047.93 | 1,930,020.93 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,578,968,285.28 | 1,549,736,500.14 | 1,527,929,463.74 | 1,484,406,409.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,460,832,117.19 | 4,483,036,476.4 | 4,618,933,142.4 | 4,639,771,116.4 |
| 流动负债: | | | | |
| 短期借款 | 72,050,138.87 | 122,088,772.74 | 291,109,026.9 | 316,129,513.07 |
| 应付票据及应付账款 | 257,671,103.88 | 290,142,371.62 | 289,632,535.92 | 281,636,610.01 |
| 应付账款 | 257,671,103.88 | 290,142,371.62 | 289,632,535.92 | 281,636,610.01 |
| 合同负债 | 131,809,489.21 | 138,198,594.14 | 156,138,519.61 | 171,942,905.82 |
| 应付职工薪酬 | 107,552,954.43 | 85,139,597.66 | 65,687,554.37 | 116,321,443.87 |
| 应交税费 | 33,482,993.53 | 20,640,822.45 | 22,115,471.18 | 18,495,037.37 |
| 其他应付款合计 | 235,846,802.31 | 266,244,471.63 | 221,323,052.75 | 216,715,643.92 |
| 应付股利 | - | 38,860,480.22 | - | 17,150,000 |
| 一年内到期的非流动负债 | 59,192,900.85 | 56,379,620.41 | 10,042,992.45 | 11,156,051.14 |
| 其他流动负债 | 15,395,114.65 | 16,768,825.12 | 19,000,794.57 | 21,327,348.72 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 913,001,497.73 | 995,603,075.77 | 1,075,049,947.75 | 1,153,724,553.92 |
| 非流动负债: | | | | |
| 长期借款 | 232,478,101.83 | 221,894,663.83 | 257,622,158.69 | 261,317,020.83 |
| 租赁负债 | 7,926,615.98 | 8,004,248.86 | 9,038,934.34 | 10,882,204.62 |
| 递延收益 | 46,671,221.31 | 48,788,238.32 | 47,315,342.08 | 50,128,726.8 |
| 递延所得税负债 | 2,365,473.97 | 1,763,869.61 | 2,376,472.64 | 3,077,234.42 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 289,441,413.09 | 280,451,020.62 | 316,352,907.75 | 325,405,186.67 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,202,442,910.82 | 1,276,054,096.39 | 1,391,402,855.5 | 1,479,129,740.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 414,019,506 | 414,019,506 | 414,019,506 | 414,019,506 |
| 资本公积 | 1,096,470,388.45 | 1,100,278,291.07 | 1,100,290,935.5 | 1,101,824,940.85 |
| 减:库存股 | 25,312,613.12 | - | - | - |
| 其他综合收益 | -5,242,399.78 | -5,159,205.96 | -4,615,144.78 | -4,249,206.87 |
| 盈余公积 | 271,042,124.11 | 271,042,124.11 | 271,042,124.11 | 271,042,124.11 |
| 未分配利润 | 1,412,213,717.81 | 1,310,581,739.62 | 1,337,583,373.29 | 1,275,842,626.11 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,163,190,723.47 | 3,090,762,454.84 | 3,118,320,794.12 | 3,058,479,990.2 |
| 少数股东权益 | 95,198,482.9 | 116,219,925.17 | 109,209,492.78 | 102,161,385.61 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,258,389,206.37 | 3,206,982,380.01 | 3,227,530,286.9 | 3,160,641,375.81 |
| 负债和股东权益合计 | 4,460,832,117.19 | 4,483,036,476.4 | 4,618,933,142.4 | 4,639,771,116.4 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |